ABBIOSCI is a US-based biotechnology company found in 2010. Our main focus is to make suitable, workable and applicable format antibodies and develop antibody-based products by using established technical platform, Multiple-Format-Antibody (MFAbs). There are four available formats, polyclonal antibody (pAb), monoclonal antibody (mAb), recombinant antibody (rAb) and antibody engineering (Ab-Eng). Characterization, combination, conversion and engineering of each format of antibody are applied to customers project from case to case. New generation of antibody to novel and difficulty targets and their engineering are also provided.
